Touyun Biotech Group (SEHK:1332) Balance Sheet Analysis 2009-2025

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Metric	2024	2025
Total Cash And Short-Term Investments	HK$69.644M	HK$5.063M
Net Receivables	HK$22.284M	HK$26.06M
Inventory	HK$24.585M	HK$18.241M
Prepaid Expenses And Other Current Assets	HK$40.88M	-
Other Current Assets	HK$16.66M	HK$48.981M
Total Current Assets	HK$174.053M	HK$98.345M
Property, Plant And Equipment	HK$280.176M	HK$242.192M
Goodwill And Intangible Assets	-	-
Long-Term Investments	HK$95.902M	HK$279.167M
Deferred Tax Assets	-	-
Other Noncurrent Assets	HK$188K	-
Total Noncurrent Assets	HK$376.266M	HK$521.359M
Other Assets	-	-
Total Assets	HK$550.319M	HK$619.704M

Metric	2024	2025
Total Payables	HK$12.695M	HK$7.973M
Accrued Expenses	-	-
Short-Term Debt	HK$341.482M	HK$413.271M
Current Portion Of Lease Obligations	HK$10.129M	-
Income Taxes Payable	-	-
Current Deferred Revenue	-	HK$5.555M
Other Current Liabilities	HK$193.677M	HK$164.65M
Total Current Liabilities	HK$557.983M	HK$591.449M
Long-Term Debt	HK$20.636M	HK$-0.353M
Capital Lease Obligations	HK$16.3M	HK$0.353M
Noncurrent Deferred Revenue	-	-
Noncurrent Deferred Tax Liabilities	-	-
Other Noncurrent Liabilities	-	HK$511K
Total Noncurrent Liabilities	HK$32.978M	HK$0.864M
Other Liabilities	-	-
Total Liabilities	HK$590.961M	HK$592.313M

Metric	2024	2025
Treasury Stock	-	-
Preferred Stock	-	-
Common Stock	HK$112.238M	HK$112.238M
Retained Earnings	HK$-2.137B	HK$-0.163B
Additional Paid-In Capital	HK$1.873B	-
Accumulated Other Comprehensive Income	HK$68.493M	-
Other Stockholders' Equity	-	-
Total Common Stockholders' Equity	HK$-83.2M	HK$-51.098M
Minority Interest	HK$42.558M	HK$78.489M
Total Equity	HK$-40.642M	HK$27.391M
Total Liabilities And Equity	HK$550.319M	HK$619.704M

Metric	2024	2025
Total Investments	HK$149.229M	HK$279.167M
Total Debt	HK$384.589M	HK$413.624M
Net Debt	HK$368.272M	HK$408.561M

Touyun Biotech Group Balance Sheet

Balance Sheet Composition